Yuni 4, 2010 - Yin amfani da statins - dangin magunguna don rage matakan cholesterol na jini - na iya haifar da sakamako masu illa da yawa da suka shafi idanu, hanta, kodan da tsokoki.

Masu bincike na Biritaniya ne suka nuna hakan waɗanda suka yi nazarin bayanan fiye da marasa lafiya miliyan 2, 16% waɗanda aka riga aka yi musu magani da statins.

Bisa ga bayanan da aka tattara, ga kowane masu amfani da 10, shan statins fiye da shekaru 000 yana hana 5 lokuta na cututtukan zuciya, da kuma 271 yawan lokuta na ciwon daji na esophageal.

Duk da haka, yana haifar da ƙarin lokuta 307 na cataracts, lokuta 74 na rashin aikin hanta, lokuta 39 na myopathy da 23 ƙarin lokuta na matsakaici ko tsanani na gazawar koda, kuma ga kowane masu amfani da miyagun ƙwayoyi fiye da shekaru 10.

Wadannan illolin sun bayyana akai-akai a cikin maza kamar na mata, ban da myopathy - ko lalacewar tsoka - wanda ya shafi kusan sau biyu na maza fiye da mata.

Kuma idan waɗannan illolin sun faru a cikin shekaru 5 da aka bi marasa lafiya, musamman a lokacin 1^re shekarar jinyar su ne suka fi yawa.

Wadannan bayanan sun shafi kowane nau'in statins da aka yi amfani da su a cikin binciken, watau simvastatin (wanda aka tsara don sama da 70% na mahalarta), atorvastatin (22%), pravastatin (3,6%), rosuvastatin (1,9%) da fluvastatin (1,4) ,XNUMX%).

Koyaya, fluvastatin ya haifar da ƙarin matsalolin hanta idan aka kwatanta da sauran nau'ikan statins.

A cewar masu binciken, wannan binciken yana daya daga cikin 'yan kaɗan don auna girman sakamakon cutarwa na shan statins - mafi yawan kwatanta tasirin waɗannan akan rage haɗarin cututtukan zuciya zuwa placebo.

Har ila yau, sun yi imanin cewa matsalolin da aka lura bai kamata su rufe kashi 24% na raguwar cututtukan cututtukan zuciya da shan kwayoyi ya tanada ba, a cikin tsarin wannan binciken.

Kara sauraron marasa lafiya

Dangane da illolin da aka lissafa a cikin wannan binciken, masu binciken sun ba da shawarar cewa likitocin su bi majiyyatan su da sauri don gano illar da ka iya faruwa, don daidaitawa ko dakatar da magungunan su, idan ya cancanta.

Wannan kuma shi ne ra'ayin likitan zuciya Paul Poirier, darektan shirin rigakafin zuciya da gyaran zuciya a Institut de cardiologie et de pneumologie de Québec.

"Wannan binciken yana ba mu ainihin ƙididdiga game da abubuwan da suka faru na mummunan tasiri, kuma suna da tsanani," in ji shi. Bugu da ƙari, a cikin asibiti, lokacin da mai haƙuri da aka yi wa statins ya sha wahala daga dystrophy na muscular ko matsalolin hanta, an dakatar da magani. "

Babban haɗarin fama da cataracts yana ba Paul Poirier mamaki. "Wannan bayanin sabo ne kuma ba karamin abu bane tunda yana shafar tsofaffi da suka rigaya basu da lafiya, wanda akwai haɗarin ƙara ƙarin matsala," in ji shi.

A cewar likitan zuciya, sakamakon kuma gargadi ne ga kasashen da ke juggling ra'ayin samar da statins ba tare da takardar sayan magani ba.

"A bayyane yake cewa amfani da statins yana buƙatar saka idanu kuma yana buƙatar a sanar da marasa lafiya da kyau game da illa masu illa," in ji likitan zuciya.

Amma fiye da haka, binciken na Burtaniya ya zama tunatarwa ga likitocin da ke kula da marasa lafiyar su da statins.

"Statin magani ne wanda ke ɗaukar haɗari kuma dole ne mu bi marasa lafiya a hankali. Fiye da duka, dole ne mu saurara kuma mu yarda da mara lafiyar da ke gunaguni game da alamun cutar, koda kuwa ba a lissafa waɗannan a cikin wallafe-wallafen kimiyya ba: mara lafiya ba ƙididdiga ba ne ko matsakaici kuma dole ne a bi da shi ta wata hanya ta musamman, ”in ji D.^r Itacen pear.

Martin LaSalle - PasseportSanté.net

1. Hippisley-Cox J. et al, Abubuwan da ba a yi niyya na statins a cikin maza da mata a Ingila da Wales: nazarin ƙungiyar jama'a ta amfani da bayanan bincike na QResearch, British Medical Journal, buga online 20 Mayu 2010,; 340: c2197.

2. Rosenberg H, Allard D, Prudence wajibi: amfani da statins a cikin mata, Ayyukan kare lafiyar mata, Yuni 2007.